Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.
about
Current status and future role of brain PET/MRI in clinical and research settings.Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.Advances in MRI assessment of gliomas and response to anti-VEGF therapy.Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patientsEmerging treatment strategies for glioblastoma multiformeAn intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlatesRelapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomographyAn automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET.Optical-sectioning microscopy of protoporphyrin IX fluorescence in human gliomas: standardization and quantitative comparison with histology.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Neurologic Applications of PET/MR Imaging.The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.11C-MET PET/MRI for detection of recurrent glioma.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
P2860
Q30883711-D8F1CF2F-FDB6-4323-BDF2-650AD162006FQ33719890-EE0CBAF6-B086-4D30-9D20-42C11F085711Q33793253-6424B644-9B31-461E-B8C6-83A9C9616794Q34533978-0E30993B-1F77-4AB7-92AA-58A20A0A85EDQ34542656-B5621C90-F243-4080-A58E-81EC08A0FC8CQ35156126-4211B807-FBB7-4D14-AB8D-6ED4ADC3D295Q35835743-16540658-5AC1-4331-9848-AAC2F70774B1Q36644371-E6E3561A-DDA1-4DD2-B4AC-E98C0BC98FFFQ37037922-589BB94B-B546-465A-82BF-9CE87BC3383CQ37235829-CFBE4837-39B4-48AB-945E-44429B1021EEQ37703206-5FBB9406-7493-4E70-8C73-8D727EBEF9F9Q38728989-1F4F4B1E-F3D0-4A6B-AE54-19E00E6DB22FQ38815396-7D4E8722-9387-4488-9261-4A684A50330CQ38846608-C4DECA1A-B6CC-423A-B43C-045D9A1CDE95Q40010516-45E1C879-5E30-466C-8C13-4CFE65ED907EQ41994160-9926E276-CB0B-4B87-B210-E4505E4AF236Q44461998-7E633C43-122D-41F6-B8B4-557C82BE452BQ47241150-4920B8A4-DB99-4717-8E05-D78F5F55E348Q48158155-BB53F803-6C47-45A7-9649-93EBA4C5BC8FQ48241629-2ADE3643-A10D-4B72-8E69-7E165AE6FBD5Q48673004-EDA1F9E4-E409-4FF9-8F52-A814CD3E81FBQ52950126-6363AA23-F132-421E-ADE6-F7422043CA91Q53261272-C29C571D-8718-41E9-8121-2FFE0CD75999Q55462330-C392742E-3E1D-49FB-8F26-9DE0AA1FF73EQ58711755-8689E59A-B63F-4464-9F2E-C123251BFF7D
P2860
Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Volumetry of [
@nl
Volumetry of [(11)C]-methionin ...... rrent glioblastoma multiforme.
@en
type
label
Volumetry of [
@nl
Volumetry of [(11)C]-methionin ...... rrent glioblastoma multiforme.
@en
prefLabel
Volumetry of [
@nl
Volumetry of [(11)C]-methionin ...... rrent glioblastoma multiforme.
@en
P2093
P2860
P1476
Volumetry of [(11)C]-methionin ...... rrent glioblastoma multiforme.
@en
P2093
Andreas H Jacobs
Lutz W Kracht
Michael Schroeter
Norbert Galldiks
Roland Ullrich
P2860
P2888
P356
10.1007/S00259-009-1219-5
P577
2010-01-01T00:00:00Z